NLRP3 and metabolic dysfunction-associated steatohepatitis: Mitochondria-injury-related ROS release can induce NLRP3 inflammasome activation-mediated proinflammatory cytokine expression and aggravate the NASH development (Kim et al., 2020; Wu et al., 2020).